# Clustering Approach 1 : CN_CNMF
Index	Clinical feature name	Test type	P value	Comment
1	Time to Death	logrank test	0.0105394931133642	Range of duration = 0.07 to 72.23, nDeath = 15, nCensor = 90
2	AGE	ANOVA	0.178492201945834	Range of values = 41 to 90, Mean = 67.9139, StdDev = 10.6695, nMissing = 7
3	GENDER	Chi-square test	0.0388420788805615	nTypes = 2 (FEMALE/MALE), nPatients = 60/98
4	HISTOLOGICAL.TYPE	Chi-square test	0.103790864732005	nTypes = 6 (STOMACH ADENOCARCINOMA - DIFFUSE TYPE/STOMACH ADENOCARCINOMA - NOT OTHERWISE SPECIFIED (NOS)/STOMACH INTESTINAL ADENOCARCINOMA - MUCINOUS TYPE/STOMACH INTESTINAL ADENOCARCINOMA - PAPILLARY TYPE/STOMACH INTESTINAL ADENOCARCINOMA - TUBULAR TYPE/STOMACH INTESTINAL ADENOCARCINOMA - TYPE NOT OTHERWISE SPECIFIED (NOS)), nPatients = 16/89/7/3/10/28, nMissing = 5
5	PATHOLOGY.T	Chi-square test	0.279023260810871	nTypes = 4 (T1/T2/T3/T4), nPatients = 6/52/61/18, nMissing = 21
6	PATHOLOGY.N	Chi-square test	0.116605331684555	nTypes = 4 (N0/N1/N2/N3), nPatients = 44/57/24/15, nMissing = 18
7	PATHOLOGICSPREAD(M)	Chi-square test	0.909046508965283	nTypes = 3 (M0/M1/MX), nPatients = 134/16/8
8	TUMOR.STAGE	Chi-square test	0.923695136716952	nTypes = 4 (I/II/III/IV), nPatients = 24/37/43/26, nMissing = 28
9	RADIATIONS.RADIATION.REGIMENINDICATION	Chi-square test	0.316165319776223	nTypes = 2 (NO/YES), nPatients = 5/153
10	NEOADJUVANT.THERAPY	Chi-square test	0.053872801504137	nTypes = 2 (NO/YES), nPatients = 11/147